Dipyridamole and vascular healing following stent implantation

INTRODUCTION: Patients undergoing coronary stent implantation incur a 2% annual rate of adverse events, largely driven by in-stent restenosis (ISR) due to neointimal (NI) tissue proliferation, a process in which smooth muscle cell (SMC) biology may play a central role. Dipyridamole (DP) is an approv...

Descripción completa

Detalles Bibliográficos
Autores principales: Simard, Trevor, Jung, Richard, Di Santo, Pietro, Labinaz, Alisha, Short, Spencer, Motazedian, Pouya, Dhaliwal, Shan, Sarma, Dhruv, Rasheed, Adil, Ramirez, F. Daniel, Froeschl, Michael, Labinaz, Marino, Holmes, David R., Alkhouli, Mohamad, Hibbert, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514894/
https://www.ncbi.nlm.nih.gov/pubmed/37745122
http://dx.doi.org/10.3389/fcvm.2023.1130304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514894/
https://www.ncbi.nlm.nih.gov/pubmed/37745122
http://dx.doi.org/10.3389/fcvm.2023.1130304

Ejemplares similares